Article FDA Thank You Explainer: What a government shutdown would mean for the FDA (Updated)
Agency IQ
MARCH 1, 2024
For example, statutorily, the prescription drug user fee program (PDUFA) has a statutory cap of total carryover for operating reserves of 14 weeks, while the biosimilar user fee program (BsUFA) had a goal of bringing the carryover balance down to “no greater than 21 weeks of operating reserves” by the end of the 2022 fiscal year.
Let's personalize your content